Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID PRESCOTT TIETJEN

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1508838384
CMS profile
159288
Location
HUNTSVILLE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$279.61

18 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $279.61 18

By paying entity

PY2020 · entire year · sorted by reported total

Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID PRESCOTT TIETJEN

NPI 1508838384 · CMS profile ID 159288

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

HUNTSVILLE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1508838384?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID PRESCOTT TIETJEN, NPI 1508838384, CMS profile ID 159288. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1508838384?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). DAVID PRESCOTT TIETJEN, NPI 1508838384, CMS profile ID 159288. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1508838384?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
DAVID PRESCOTT TIETJEN, NPI 1508838384, CMS profile ID 159288, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1508838384?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

18 matching records · $279.61 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 18 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–18 of 18.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
OPKO Pharmaceuticals, LLC $15.2611/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752238093 CMS
AstraZeneca Pharmaceuticals LP $13.9211/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736383989 CMS
Horizon Therapeutics plc $15.0011/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 721448721 CMS
AstraZeneca Pharmaceuticals LP $18.9309/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736274835 CMS
Relypsa, Inc. $13.8409/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 742199549 CMS
Novartis Pharmaceuticals Corporation $15.5707/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726160769 CMS
OPKO Pharmaceuticals, LLC $11.9907/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752238089 CMS
Alexion Pharmaceuticals, Inc. $14.4607/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 726636247 CMS
AKEBIA THERAPEUTICS INC $18.5806/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753171637 CMS
Relypsa, Inc. $12.3105/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 742204009 CMS
OPKO Pharmaceuticals, LLC $14.4003/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752238095 CMS
AKEBIA THERAPEUTICS INC $16.4903/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753171635 CMS
Otsuka America Pharmaceutical, Inc. $23.0802/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748801989 CMS
OPKO Pharmaceuticals, LLC $19.7502/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 752238091 CMS
Takeda Pharmaceuticals U.S.A., Inc. $12.7702/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747312973 CMS
Otsuka America Pharmaceutical, Inc. $16.5701/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 748801987 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.2001/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747312971 CMS
AstraZeneca Pharmaceuticals LP $12.4901/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736245931 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $462.83 30
PY2020 $279.61 18
PY2021 $646.77 24
PY2022 $630.15 34
PY2023 $655.62 29
PY2024 $538.52 20
PY2025 $311.01 12

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $86,493.87 37
PY2024 Principal investigator $77,411.65 31
PY2023 Principal investigator $244,765.38 77
PY2022 Principal investigator $437,199.28 132
PY2021 Principal investigator $475,627.60 160
PY2020 Principal investigator $841,410.33 80
PY2019 Principal investigator $476,990.58 451

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

160 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim International GmbH $2,490.00 12/22/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342715
Principal investigator 1 Boehringer Ingelheim International GmbH $11,070.00 11/19/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342705
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 11/15/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440393
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 11/15/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440697
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 11/15/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440703
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 11/15/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440708
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 11/15/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440713
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 11/15/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440719
Principal investigator 1 GlaxoSmithKline, LLC. $2,302.30 11/04/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809541761
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,102.20 11/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440387
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $12,198.93 10/31/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 827031127
Principal investigator 1 Boehringer Ingelheim International GmbH $10,820.00 10/27/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342731
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 10/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440381
Principal investigator 1 GlaxoSmithKline, LLC. $2,535.39 10/15/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809526239
Principal investigator 1 GlaxoSmithKline, LLC. $749.97 10/15/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809541737
Principal investigator 1 GlaxoSmithKline, LLC. $243.10 10/15/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809541755
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $12,198.93 09/30/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 827031115
Principal investigator 1 Boehringer Ingelheim International GmbH $4,960.00 09/27/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342711
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $12,198.93 08/31/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 827031113
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440363
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,062.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440369
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440637
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440643
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440649
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440655
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440661
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440667
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440673
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440679
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440685
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 08/20/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440691
Principal investigator 1 Boehringer Ingelheim International GmbH $1,585.00 08/18/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342713
Principal investigator 1 AKEBIA THERAPEUTICS INC $460.50 08/02/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855439515
Principal investigator 1 AKEBIA THERAPEUTICS INC $2,500.00 08/02/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855439539
Principal investigator 1 GlaxoSmithKline, LLC. $1,000.00 07/19/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809506229
Principal investigator 1 GlaxoSmithKline, LLC. $10,500.00 07/15/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809542171
Principal investigator 1 AKEBIA THERAPEUTICS INC $750.00 07/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440293
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,116.00 07/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440297
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,441.00 07/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440304
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,500.00 07/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440310
Principal investigator 1 AKEBIA THERAPEUTICS INC $3,024.00 07/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440317
Principal investigator 1 AKEBIA THERAPEUTICS INC $3,150.00 07/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440321
Principal investigator 1 AKEBIA THERAPEUTICS INC $3,252.00 07/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440327
Principal investigator 1 AKEBIA THERAPEUTICS INC $6,187.00 07/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440333
Principal investigator 1 GlaxoSmithKline, LLC. $1,760.85 06/20/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809506179
Principal investigator 1 Boehringer Ingelheim International GmbH $2,115.00 06/16/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342709
Principal investigator 1 GlaxoSmithKline, LLC. $27,423.63 06/10/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 860867907
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $12,198.93 05/31/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 827031117
Principal investigator 1 Boehringer Ingelheim International GmbH $9,975.00 05/19/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342719
Principal investigator 1 GlaxoSmithKline, LLC. $2,823.75 05/19/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809503523
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $24,397.86 04/30/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 827031119
Principal investigator 1 Boehringer Ingelheim International GmbH $11,135.00 04/14/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342717
Principal investigator 1 AstraZeneca Pharmaceuticals LP $41,298.42 04/06/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS, LLC
A Phase 2a Randomized Double blind Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI3506 in Subjects with Diabetic Kidney Disease No dispute reported 06/30/2026 826478955
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $18,298.40 03/31/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 827031121
Principal investigator 1 AKEBIA THERAPEUTICS INC $53.60 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431717
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431731
Principal investigator 1 AKEBIA THERAPEUTICS INC $400.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431743
Principal investigator 1 AKEBIA THERAPEUTICS INC $506.17 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431753
Principal investigator 1 AKEBIA THERAPEUTICS INC $514.05 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431755
Principal investigator 1 AKEBIA THERAPEUTICS INC $2,500.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431777
Principal investigator 1 AKEBIA THERAPEUTICS INC $10,000.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431801
Principal investigator 1 AKEBIA THERAPEUTICS INC $59,700.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431823
Principal investigator 1 AKEBIA THERAPEUTICS INC $100.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432795
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432803
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432805
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432807
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432809
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432811
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432813
Principal investigator 1 AKEBIA THERAPEUTICS INC $300.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432889
Principal investigator 1 AKEBIA THERAPEUTICS INC $750.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432939
Principal investigator 1 AKEBIA THERAPEUTICS INC $750.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855432955
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,500.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855433039
Principal investigator 1 AKEBIA THERAPEUTICS INC $2,500.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855433137
Principal investigator 1 AKEBIA THERAPEUTICS INC $8,500.00 03/18/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855433147
Principal investigator 1 AKEBIA THERAPEUTICS INC $75.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430427
Principal investigator 1 AKEBIA THERAPEUTICS INC $75.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430429
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430863
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430865
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430867
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430869
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430871
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430873
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430875
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430877
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430879
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430881
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430883
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430885
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430887
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855430889
Principal investigator 1 AKEBIA THERAPEUTICS INC $625.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431635
Principal investigator 1 AKEBIA THERAPEUTICS INC $625.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431637
Principal investigator 1 AKEBIA THERAPEUTICS INC $625.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431639
Principal investigator 1 AKEBIA THERAPEUTICS INC $625.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431641
Principal investigator 1 AKEBIA THERAPEUTICS INC $625.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431643
Principal investigator 1 AKEBIA THERAPEUTICS INC $625.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431645
Principal investigator 1 AKEBIA THERAPEUTICS INC $625.00 03/17/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855431647
Principal investigator 1 Boehringer Ingelheim International GmbH $2,620.00 03/17/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342707
Principal investigator 1 Boehringer Ingelheim International GmbH $2,620.00 03/17/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342723
Principal investigator 1 AKEBIA THERAPEUTICS INC $12,713.45 03/15/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440457
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440463
Principal investigator 1 AKEBIA THERAPEUTICS INC $871.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440469
Principal investigator 1 AKEBIA THERAPEUTICS INC $914.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440475
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440725
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440731
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440737
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440743
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440749
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440755
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440761
Principal investigator 1 AKEBIA THERAPEUTICS INC $830.00 03/09/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440767
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $12,198.93 02/28/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 827031123
Principal investigator 1 Boehringer Ingelheim International GmbH $1,460.00 02/24/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342721
Principal investigator 1 Boehringer Ingelheim International GmbH $1,460.00 02/24/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342729
Principal investigator 1 AKEBIA THERAPEUTICS INC $33.75 02/22/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855421759
Principal investigator 1 AKEBIA THERAPEUTICS INC $33.75 02/22/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855422123
Principal investigator 1 AKEBIA THERAPEUTICS INC $33.75 02/22/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855422125
Principal investigator 1 AKEBIA THERAPEUTICS INC $33.75 02/22/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855422127
Principal investigator 1 AKEBIA THERAPEUTICS INC $33.75 02/22/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855422129
Principal investigator 1 GlaxoSmithKline, LLC. $8,961.03 02/11/2021 Non-covered Recipient Entity
FRESENIUS MANAGEMENT SERVICES
A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P No dispute reported 06/30/2026 809491389
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,500.00 02/02/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855421113
Principal investigator 1 AKEBIA THERAPEUTICS INC $750.00 02/02/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855421269
Principal investigator 1 AKEBIA THERAPEUTICS INC $10,471.10 02/01/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440451
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $12,198.93 01/31/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 827031125
Principal investigator 1 AKEBIA THERAPEUTICS INC $216.00 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420317
Principal investigator 1 AKEBIA THERAPEUTICS INC $216.00 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420319
Principal investigator 1 AKEBIA THERAPEUTICS INC $216.00 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420321
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420655
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420689
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420691
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420699
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420771
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855420855
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855421091
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855421093
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855421095
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855421097
Principal investigator 1 AKEBIA THERAPEUTICS INC $857.25 01/26/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855421099
Principal investigator 1 AKEBIA THERAPEUTICS INC $641.25 01/19/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855419953
Principal investigator 1 AKEBIA THERAPEUTICS INC $641.25 01/19/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855420201
Principal investigator 1 AKEBIA THERAPEUTICS INC $641.25 01/19/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855420203
Principal investigator 1 AKEBIA THERAPEUTICS INC $365.00 01/19/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440403
Principal investigator 1 AKEBIA THERAPEUTICS INC $801.00 01/19/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440409
Principal investigator 1 AKEBIA THERAPEUTICS INC $876.00 01/19/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440415
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,116.00 01/19/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440421
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,500.00 01/19/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0014 No dispute reported 06/30/2026 855440427
Principal investigator 1 AKEBIA THERAPEUTICS INC $750.00 01/13/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0017 No dispute reported 06/30/2026 855419933
Principal investigator 1 AKEBIA THERAPEUTICS INC $3,431.00 01/13/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440397
Principal investigator 1 Boehringer Ingelheim International GmbH $850.00 01/13/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342725
Principal investigator 1 Boehringer Ingelheim International GmbH $850.00 01/13/2021 Non-covered Recipient Entity
Nephrology Consultants
EMPA-KIDNEY No dispute reported 06/30/2026 828342727
Principal investigator 1 Horizon Therapeutics plc $2,106.00 01/13/2021 Non-covered Recipient Entity
FRENOVA LLC
A MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED EFFICACY AND SAFETY STUDY OF PEGLOTICASE IN PATIENTS WITH UNCONTROLLED GOUT WHO HAVE UNDERGONE KIDNEY TRANSPLANTATION No dispute reported 06/30/2026 811912477
Principal investigator 1 AKEBIA THERAPEUTICS INC $80.00 01/08/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855419793
Principal investigator 1 AKEBIA THERAPEUTICS INC $160.00 01/08/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855419805
Principal investigator 1 AKEBIA THERAPEUTICS INC $100.00 01/08/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855419849
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 01/08/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855419865
Principal investigator 1 AKEBIA THERAPEUTICS INC $125.00 01/08/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855419867
Principal investigator 1 AKEBIA THERAPEUTICS INC $750.00 01/08/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855420099
Principal investigator 1 AKEBIA THERAPEUTICS INC $1,000.00 01/08/2021 Non-covered Recipient Entity
FRENOVA LLC
AKB-6548-CI-0016 No dispute reported 06/30/2026 855420117
Principal investigator 1 AKEBIA THERAPEUTICS INC $276.00 01/06/2021 Non-covered Recipient Entity
NEPHROLOGY CONSULTANTS LLC
AKB-6548-CI-0015 No dispute reported 06/30/2026 855440445